Oral Medicine| Volume 93, ISSUE 6, P671-675, June 2002

Download started.


Fluconazole mouthrinses for oral candidiasis in postirradiation, transplant, and other patients


      Objective. Oral candidiasis is associated with multiple local and systemic factors. Morbidity and deaths, in high-risk patients, may be prevented by recognition and adequate management. Fluconazole is a systemic antifungal medication that demonstrated clinical advantages in rinsing before swallowing. The purpose of the present study was to evaluate the clinical efficacy of fluconazole aqueous mouthrinses to treat oral candidiasis. Methods. Ten women and 9 men diagnosed with oral candidiasis used fluconazole (2 mg/mL) aqueous solution 3 times per day as a rinse and-spit topical treatment. The outcome was assessed after 1 week of treatment. Results. Complete symptomatic and clinical relief was noted in 94% of the patients, and a mycologic cure was documented in all but 1 patient. No side effects were reported. Oral rinses with fluconazole suspension may be useful to manage patients with dry mouth or those who have difficulties in swallowing caused by oral candidiasis. Conclusions. Further double-blind studies are needed to establish the optimal treatment regimen and the usefulness of fluconazole mouthrinses in patients with different risk factors for infection. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:671-5)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Bodey GP
        Candidiasis in cancer patients.
        Am J Med. 1984; 77: 13-19
        • Winston DJ
        • Chandrasekar PH
        • Lazarus HM
        • Goodman JL
        • Silber JL
        • Horowitz H
        • et al.
        Fluconazole prophylaxis of fungal infections in patients with acute leukemia: results of a randomized placebo-controlled, double-blind, multicenter trial.
        Ann Intern Med. 1993; 118: 495-503
        • Bureau of HIV/AIDS and STD
        1994 Annual Report of AIDS in Canada.
        LCDC, Health Canada. 1995; : 4-26
        • Epstein JB
        Antifungal therapy in oropharyngeal mitotic infections.
        Oral Surg Oral Med Oral Pathol. 1990; 69: 32-41
        • Guida RA
        Candidiasis of the oropharynx and esophagus.
        Ear Nose Throat J. 1998; 67: 832-840
        • Dreizen S
        Oral candidiasis.
        Am J Med. 1984; 30: 28-33
        • Budtz-Jirgensen E
        • Mojon P
        • Banon-Clement JM
        • Baehni P
        Oral candidosis in long-term hospital care: comparison of edentulous and dentate subjects.
        Oral Dis. 1996; 2: 285-290
        • Judd G
        Oral candidiasis: treatment choices.
        On Contin Pract. 1989; 16: 21-22
        • Lewis MAO
        • Samaranyake LP
        • Lamey PJ
        Diagnosis and treatment of oral candidiasis.
        J Oral Maxillofac Surg. 1991; 49: 996-1002
        • Epstein JB
        • Polsky B
        Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies.
        Clin Ther. 1998; 20: 40-57
        • Hay RJ
        Overview of studies of fluconazole in oropharyngeal candidiasis.
        Rev Infect Dis. 1990; 12: 334-337
        • Koks CHW
        • Schepens NHJ
        • Burger DM
        Drug development report (9): fluconazole in the treatment and prophylaxis of oral candidosis in HIV infected patients.
        J Drug Dev Clin Pract. 1993; 5: 235-249
        • Epstein JB
        • Ransier A
        • Lunn R
        • Chin E
        • Jacobson JJ
        • Le N
        • et al.
        Prophylaxis of candidiasis in patients with leukemia and bone marrow transplants.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996; 81: 291-296
        • Philpot-Howard JN
        • Wade JJ
        • Mufti GJ
        • Brammer KW
        • Ehninger G
        Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia: multicenter study group.
        J Antimicrob Chemother. 1993; 31: 973-984
        • Force RW
        • Nahata MC
        Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis.
        Ann Pharmacother. 1995; 29: 10-15
        • Laufen H
        • Yeates RA
        • Zimmerman T
        • de los Reyes C
        Pharmacokinetic optimization of the treatment of oral candidiasis with fluconazole: studies with a suspension.
        Drugs Exp Clin Res. 1995; 21: 23-28
        • Budtz-Jorgesesn E
        Etiology, pathogenesis, therapy and prophylaxis of oral yeast infections.
        Acta Odontol Scand. 1990; 48: 61-69
        • Greenspan D
        Treatment of oropharyngeal candidiasis in HIV-positive patients.
        J Am Acad Dermatol. 1994; 31: 51-55
        • Francis P
        • Walsh TJ
        Current approaches to the management of fungal infections in cancer patients.
        Oncology. 1992; 6: 81-92
        • Rodu B
        • Carpenter JT
        • Jones MR
        The pathogenesis and clinical significance of cytologically detectable oral Candida in acute leukemia.
        Cancer. 1988; 62: 2042-2046
        • Peterson DE
        Oral candidiasis.
        Clin Geriatr Med. 1992; 8: 513-527
        • Kreher JM
        • Graser GN
        • Handelman SL
        • Eisenberg AD
        Oral yeasts, mucosal health and drug use in an elderly denture-wearing population.
        Spec Care Dentist. 1991; 11: 222-226
        • Krogh P
        • Hald B
        • Holmstrup P
        Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine.
        Carcinogenesis. 1987; 8: 1543-1548
        • Epstein JB
        • Truelove EL
        • Izutzu KT
        Oral candidiasis: pathogenesis and host defense.
        Rev Infect Dis. 1984; 6: 96-106
        • Epstein JB
        • Pearsall NN
        • Truelove EL
        Quantitative relationship between Candida albicans in saliva and the clinical status of human subjects.
        J Clin Microbiol. 1980; 12: 475-476
        • Gupta AK
        • Sauder DN
        • Shear NH
        Antifungal agents: an overview. Part 1.
        J Am Acad Dermatol. 1994; 30: 677-698
        • Kowalsky SF
        • Dixon DM
        Fluconazole: a new antifungal agent.
        Clin Pharmacol. 1991; 110: 179-194
        • Shechtman LB
        • Funaro L
        • Robin T
        • Bottone EJ
        • Cuttner J
        Clotrimazole treatment of oral candidiasis in patients with neoplastic disease.
        Am J Med. 1984; 76: 91-94
        • Goldstein SM
        Advances in the treatment of superficial Candida infections.
        Semin Dermatol. 1993; 12: 315-330
        • Epstein JB
        Oral and pharyngeal candidiasis.
        Postgrad Med. 1989; 85: 257-269